Full Year 2019 Results · Market Capitalization** 4 ... Electronic Specialty Gases 5. 6 Full Year...

Post on 31-May-2020

1 views 0 download

Transcript of Full Year 2019 Results · Market Capitalization** 4 ... Electronic Specialty Gases 5. 6 Full Year...

Full Year 2019 Results

Step-up in Performance Improvement

High level of Investments for Customers and Efficiency

Commitment to Climate Reaffirmed

Tokyo Innovation Campus

The world leader in gases, technologies and services for Industry and HealthFull Year 2019 Credit Investors

Agenda

1. Air Liquide Today – Short Introduction

2. 2019, A Landmark Year for Air Liquide

3. Performance Improvement in FY 2019

4. Group Credit Profile

5. 2020 Outlook

6. Appendix

2

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Air Liquide TodayShort Introduction

3

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

A World Leader in Gases, Technologies and Services for Industry & Health

80Countries

67,000 Employees

>3.7 mCustomers

and Patients

~€22 bnof Sales in 2019

>€2.2bn

~€5bn

>€60bn

Net Profitin 2019

Cash Flow in 2019*

Market Capitalization**

4

* cash flow from operating activities before changes of working capital** on December 31, 2019

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

A Strong Business ModelElectricity

Natural gas

Water

ESG(d)

Healthcare

Large Industries

Industrial Merchant

Electronics

Air Liquide Activities

Home healthcare

Patient

Filling

center

SMR(a)

ASU(b)

Filling center

On-site (c)

customer

Hospital

Bulk and Cylinder

Customer

Metal

Producer

Refinery

Chemical

Producer ESG(d)

Filling center

Electronics

Customer

ASU(b)

Mutualize assets

Liquefaction piggyback

Distributors, bolt-on acquisitions

1

2

3

(a) SMR: Hydrogen and carbon monoxide production unit (Steam Methane Reformer) (b) ASU: Air gases production unit (Air Separation Unit) (c) On-site: Small local production unit (d) ESG: Electronic Specialty Gases

5

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 20196

A Balanced Footprint

Gas & Services revenue in 2019

€21bn €21bn

Large Industries

27%

Electronics

9%

Healthcare

18%

Industrial

Merchant 46%

Americas

40%

Africa Middle-East

3%Europe

34%

Asia-Pacific 23%

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 20197

+6% to +8%CAGR 2016-2020(1)

>10%In 2021-2022

Maintain

“A” range rating

Capex/Sales 2017-2020: 10% to 12%

Financial Objectives Efficiencies >€300m on average/year(2)

+ Airgas synergies >$300m

(2) Upgraded from >€300m to >€400m as of 2019

(1) Including Airgas scope effect in 2017 contributing +2% to the CAGR

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 20198

Reduce our carbon intensity in 2025 vs. 2015 by

Act for clean industry by developing low-carbon solutions

CUSTOMERS

ASSETS

ECOSYSTEMS

-30%

AASSETS

CCUSTOMERS

EECOSYSTEMS

A global

approach

Financial Objectives

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

0,0

0,5

1,0

1,5

2,0

2,5

3,0

1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019

0,0

1,0

2,0

3,0

4,0

5,0

1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019

Regular and Sustained Performance

0

4 000

8 000

12 000

16 000

20 000

24 000

1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019

0

1 000

2 000

3 000

4 000

1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019

Revenue (in €m) EPS(2) (in €)

Cashflow (in €m)

(1) Calculated according to prevailing accounting rules over 30 years. (2) Adjusted for the 2-for-1 share split in 2007, for attributions of free shares and for a factor of 0.974 reflecting the value of the rights of the capital increase completed in October 2016. (3) Dividend 2019 subject to the approval of shareholders during the General Meeting on May 5, 2020

Dividend(2,3) (in € per share)

CAGR over 30 years(1)

+5.6% +6.7%

+6.5% +8.7%

CAGRover 30 years(1)

9

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

2019, A Landmark Year for Air Liquide

10

The world leader in gases, technologies and services for Industry and HealthFull Year 2019 Credit Investors

2019, A Landmark Year for Air Liquide

• Commitment to a structured plan for performance

improvement driving initial step up in margins

• Commitment to customers and efficiency

High level of investments, major signings in key basins

• Commitment to climate reaffirmed

Reduction in carbon intensity and launch of major

innovative projects

11

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 201912

Strong Performance Improvement in 2019

(1) Excluding energy impact(2) Excluding exceptional and significant operations not impacting the Operating Income Recurring(3) Return on Capital Employed based on Recurring Net Profit

+4.3%Group Sales

+11.1%Recurring Net Profit(2)

+60bpsRecurring ROCE(3)

+10.0%Operating Income RecurringOperating Margin(1)

+ 70bps

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Structured Program in Place to Deliver NEOS and Beyond

Pricing

Efficiencies

Bolt-on Acquisitions

+

+

+

Product MixManagement

TransformationPrograms

Portfolio Streamlining

… with commitment to further improve the operating margin(1).

Reinforced existing plan

ExtendedOutlook

Launchedin 2019

(1) Assuming no major change in the environment and the international health situation is under control

13

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

0

0,3

0,6

0,9

1,2

1,5

2016 2017 2018 2019

GM&T E&C

0

0,5

1

1,5

2

2,5

3

3,5

2010 2011 2012 2013 2014 2015 2016 2017 2018 2019

High Investments, Order Intake Recovering

Industrial Investment Decisions E&C and GM&T Order Intake

€3.2bn €1.4bn

14

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Proposed Dividend Distribution in 2020

(1) Historical data adjusted for past free share attributions and for a factor of 0.9067 reflecting the value of the rights of the 2016 capital increase (2) Subject to the approval of shareholders during the General Meeting on May 5, 2020

0,0

0,4

0,8

1,2

1,6

2,0

2,4

1999 2001 2003 2005 2007 2009 2011 2013 2015 2017 2019

€2.70(2)

Strong dividend increase Increase of nominal

Free share attribution

58% Payout Ratio

+ 12.4%

+9.0% 20 years CAGR Including free shares attributionevery other year

Div

ide

nd

(1)

in €

pe

r s

ha

re

15

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Further Reduction of Carbon Intensity(k

g C

O2/€

EB

ITD

A(1

) )

6.3

4.4

(1) Operating Income Recurring before Depreciation and at 2015 exchange rate

Reduction of

Carbon intensity

from 2015 to 2025

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

2019 Achievement

-30%

Climate Objectivesannounced in Nov. 2018

in kg CO2/€ EBITDA(1)

Initial Carbon Intensity Commitment

4.6

*16

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Launch of Major Innovative Projects

CCS(1) Green H2

Low CO2

ProductionH2 Mobility

MOU with Northern Lights

Electrolyzer in Quebec

HyGreen Provence

thyssenkrupp

ArcelorMittal

California

China

Paris

Consortia with Ports of Antwerp and

Rotterdam

(1) Carbon Capture and Storage

17

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 201918

Performance Improvement in FY 2019

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Step-up in Performance Improvement

ROCE(2)OIR/sales

17.3%

CF/sales(1)

22.2% 8.6%

(1) Cash Flow from Operations before changes in Working Capital Requirement on Group Sales (2) Recurring ROCE, based on Recurring Net Profit

Group Sales

+4.3%

Performance

As published figures

19

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Regardless of the Environment, Robust FY Sales Growth

+2.1% FX Impact -1.4% Energy Impact +0.4% ScopeFY Group Sales:

20

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

EL

HC

Q4 2019 Market Trends to Continue in Q1 2020

Chemicals

Oil & gas

Steel

Metal Fab.

Construction

Energy

Food & Pharma

Techno & Research

Integrated Circuit

IM

LI

Medical gases

Home Healthcare

IC market rebound expected driven by development of 5G and IoT

Soft Chemicals and Steel

Sustained demand for Refining in Europe

New projects across markets

Widening contrasts in markets:

- Growing Consumption and Technology sectors

- Softening IP-related sectors

Healthcare strong fundamentals

21

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

LI

Q4 – Stable Americas, Very Solid Europe

SalesFY 2019

€8,460m

SalesFY 2019

€7,172m

Americas – Major Customer Turnarounds in LI

Europe – Growth Driven by HC and Resilient IM

G&S comparable sales growth

- solid H2 for Refining in Benelux- soft Steel and Chemicals in Germany

- positive pricing- positive mix: cylinders outpacing bulk

- high organic growth in HHC - solid Medical Gases

IM

HC

EL

LI

IM

HC

- customer turnarounds

- solid pricing- widening contrasts in markets- gas sales up, hardgoods down -9%

- strong Medical Gases in US and dynamic Latin America

- strong Carrier Gases- high YoY E&I comparison basis

22

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Q4 – Solid Asia, Stable AME

Asia – Robust EL, Solid LI, Resilient IM

AME – Solid Activity

SalesFY 2019

€4,794m

SalesFY 2019

€614m

G&S comparable sales growth

- O2 Ramp-Ups in China for Chemicals

- China: strong cylinder volumes, lowerbulk pricing

- strong helium sales

- slowing Australia and Japan

- >+10% excluding E&I- very strong Advanced Materials

- major production units stable atfull load

- Egypt and India outpacing Africa

LI

IM

EL

LI

IM

23

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Confirmed Step-Up in OIR Margin: +70 bps

including +10bps from IFRS 16

24

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Structured Performance Improvement Program

Portfolio ManagementPrice/Mix Efficiencies

+70bps OIR margin(1)

(1) Operating Income on sales excluding energy impact in FY 2019

25

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

+0.9%

+1.7%

+3.3%+3.2%

Pursued Management of Pricing and Product Mix

IM pricing momentum Q4 margin contributors

2016 2017 2018 2019

• Focus on high value added applications

• Higher cylinder growth compared to bulk in IM

• Less E&I in EL and hardgoods in IM

• High helium pricing continuing in 2020

• 2020 Price campaigns planned

26

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Strengthened Efficiency Program Delivering

On top of existing procurement and industrial efficiencies:

Pursued digital deployment with strong momentum in LI

On-going reorganizationsespecially in IM and HHC Europe

Airgas significant contributor to the 2019 increase

2019 efficiencies

Cumulated efficiencies

2017 2018 2019

€433m

+23%

2017-2020

€1.1bn

>€1.5bn

~30% linked to energy transition

27

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Continuous Portfolio Management

2 in Europe

1 in Asia: Fujian

2 at Airgas, 1 in Asia

4 at Airgas and 6 in China

1 in Canada and 1 in UK

1 in Netherlands

Focus on Core business Densification of operations

6 Divestitures in 2019 24 Acquisitions in 2019

9 including potential sale of Schülke

On-going

including

28

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Strong Recurring Net Profit

+11.1%Recurring Net profit

Excluding one-offs: - Fujian in 2019 - financial gain in 2018

29

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Regular ROCE Improvement

6%

8%

10%

Dec. 15 Dec. 16adjusted

Dec. 17 Dec. 18 Dec. 19 2021/222021/2022NEOS

objective

>10%

Airgasacquisition

10.3%

6.9%

ROCE – After tax

(1) Excluding positive impact on 2017 net profit of non-cash one-off items (2) Recurring ROCE based on Recurring Net Profit and excluding IFRS16

7.7%(1)8.0%

+60bps

8.6%(2)

30

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

FY 18 Q3 19 FY 19FY 2018 FY 2019

InvestmentOpportunities(1)

12-month portfolio

Investment Decisions(1)

Start-up/Ramp-upSales Growth Contribution

• Mostly Chemicals, Oil & Gas, IC

• Increased number of takeovers

• Major signings in key basins

• Contract renewals & acceleration of efficiency investments

• ~30% linked to ClimateBiomethane, PEM electrolyzer in Canada

• 18 Start-Ups FY

• Q4 2019: 1 additional SU in EL China

€2.9bn €3.7bn

FY 2018 FY 2019

€336m

(1) See definitions in appendix

High Level of Investments for Customers and Efficiency

31

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Confirmed 2020 Estimated Contribution from Start-Ups

Major Start-Ups

Sales growth contribution

2019

Q1 Q2 Q3 Q4

LIProject

South America

Increased Backlog €2.8bn

Yearly Sales Backlogafter full Ramp-ups

€ 0.9bn

2020

Q1 Q2 Q3 Q4

ELProject

Asia

LIProject

Asia

LIProject

US

LIProject

Europe

LIProjectCanada

ELProject

Asia

ELProject

Asia

~€230m

FY 2020

32

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Group Credit Profile

33

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

1,59 1,63 1,70

3,302,60 2,40

0,000,200,400,600,801,001,201,401,601,802,002,202,402,602,803,003,203,403,603,804,004,204,404,604,805,005,205,405,605,806,006,206,406,606,807,007,207,407,607,808,008,208,408,608,809,009,209,409,609,8010,00

2 000

4 000

6 000

8 000

10 000

12 000

14 000

16 000

2013 2014 2015 2016 2017 2018 2019

Net Debt Net Debt / EBITDA

Net Debt ratios under control

DEBT/ EQUITY

56%

DEBT/ EQUITY

53%

DEBT/ EQUITY

57%

DEBT/ EQUITY

90%

DEBT/ EQUITY

69%

In €m

DEBT/ EQUITY

80%

Following the acquisition of

12,37312,535

2.08x

DEBT/ EQUITY

64%

34

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

High Cash Flow and Gearing Reduction

(1) Including acquisitions, transactions with minority shareholders, net of divestitures (2) Including share purchases and capital increases (3) 21.0% excluding IFRS16

Net Debt31 Dec. 2018

Net Debt31 Dec. 2019

Gearing

69%

Gearing

64%

Cash Flow

22.2%of sales(3)

35

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

A Well-diversified Financing StructureAs of December 31, 2019

EUR 45%

USD 40%

JPY 2%

Other 13%

Currencies – Net debtSources

36

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Financing Structure

As of December 31, 2019

Group gross debt maturity profileAvailable liquidity

CONFIRMED CREDIT LINES

78%

• Holdings’ Confirmed Credit Lines are a mix of bilateralfacilities for €1.1bn and a €2.5bn Revolving Credit Facility

• “Adequate” liquidity profile (S&P)

- 1 syndicated credit line : €2.5bn

CASH ANDCASH EQUIVALENT

22%

- 7 bilateral facilities : €1.1bn

€4.6bn

< 1 year

> 5 years

Between

1 and 5 years

37

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Financing Structure

As of December 31, 2019

2,00%

3,00%

4,00%

5,00%

2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019

3%3,2%

3%

FIXEDRATE

93%

VARIABLERATE

7%

Average cost of net debt Fixed/variable rates(gross debt)

38

Duration6,2 years

Debt refinancing in excellent market conditions

June 2019 €600m 0,625% EMTN 11-year public bondSept 2019 $500m 2,25% US 10-year public bond

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

“A” Long Term Credit Rating Commitment

■ Long-term rating: A-

■ Short-term rating: A-2

■ Outlook: Positive on 22 July 2019

■ Rationale:

○ “L’Air Liquide has achieved internal cost savings andsynergies quicker than we expected following the Airgasacquisition. Moreover, the market environment forindustrial gases is supportive and the company hasimplemented a disciplined financial policy and thusimproved its balance sheet credit profile in the past years.”

○ “The outlook is positive because we may raise the rating inthe next 12-24 months, should we see adjusted FFO to debtimproving sustainably above 30%”.

■ Long-term rating: A3

■ Short-term rating: P-2

■ Outlook: Stable on 28 June 2019

■ Rationale:

○ “Air Liquide’s A3 rating reflects its leading position in theoligopolistic industrial gas market with a high degree ofrevenue visibility from long-term take or pay contracts. […]The rating furthermore benefits from a well spreadexposure across different customers, industries andgeographies as well as solid and stable profitability levels.”

○ “The stable outlook reflects our expectation that Air Liquidewill continue to reduce its leverage, albeit at a slow pace,and generate substantial cash over the next 18 months.”

40

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

2020 Outlook

41

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

“Assuming no major change in the

environment and the international

health situation is under control,

Air Liquide is confident in its ability

to further increase its operating

margin and to deliver net profit

growth in 2020, at constant

exchange rate.”

2020 Outlook

Diverse End

Markets

Resilient Business

Model

StrongInvestment

Backlog

Performance Improvement

Program

42

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Appendix

43

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

FY 2019 G&S Revenue Breakdown by Region

Americas

€8.5bn

Europe

€7.2bn Asia-Pacific

€4.8bn

Large Industries ElectronicsHealthcareIndustrial Merchant

€21,040m

44

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Americas

Q4 Gas & Services Sales: €2,106m

INDUSTRIAL MERCHANT LARGE INDUSTRIES HEALTHCARE ELECTRONICS

(1)

• Widening contrasts between markets:

- stronger Food, Pharma, Research

- lower Construction and Metal Fab• Solid pricing +3.9%• Positive gas sales, hardgoods

down -9%

• Heavy customer turnarounds in U.S.: -5% of Americas sales

• Strong cogen in U.S.

• Dynamic Latin America

• Major new signing

• Strong Medical Gases in U.S. for Proximity care

• High HHC and Medical gases in Latin America

• Limited impact of bolt-onacquisitions

• Strong Carrier Gases

• High YoY E&I comparison basis

45

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Europe

Q4 Gas & Services Sales: €1,819m

INDUSTRIAL MERCHANT LARGE INDUSTRIES HEALTHCARE

(1)

(1) Excluding energy impact

• Solid H2 demand for refining in Benelux

• Soft steel and chemicals

• Ramp-Ups in Eastern Europe

• Resilient activity in all geographies

• Solid pricing at +2.5%

• Positive mix: cylinderoutpacing bulk

• High organic growth in HHC with strong Diabetes

• Solid Medical Gases and Hygiene

• Contribution from small acquisitions fully offset by divestitures

46

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Asia-Pacific

Q4 Gas & Services Sales: €1,182m

INDUSTRIAL MERCHANT LARGE INDUSTRIES ELECTRONICS

(1)

(1) Excluding energy impact

• O2 Ramp-Ups in China for Chemicals

• High H2 volumes in Singapore

• Low Australia and Japan

• Recovering pricing: +1.4%, incl. Helium

• China: strong cylinder volumes, lower bulk pricing

• Slowing Australia and Japan

• Acquisition in Malaysia

• >+10% excluding E&I, especially in China, Korea and Taiwan

• Very strong Advanced Materialsin Korea and China

• Significant decrease in E&I compared to 2018 exceptional level

47

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Q4 – Resilient IM, LI Stable Despite Turnarounds

SalesFY 2019

€5,629m

SalesFY 2019

€9,754m

Large Industries – No Start-Ups in Q4

G&S comparable sales growth

Industrial Merchant – Sustained Pricing Compensating Lower Volumes

solid Refining in Benelux with high H2

volumes

heavy customer turnarounds in Americas

soft Chemicals in Europe and low Steel

solid pricing at +3.2%

growing gas sales; drop in hardgoods

unequal end markets:- Strong Food, Pharma, and Techno- Weak Construction and Metal Fab

48

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Q4 – Consistent High HC, Strong EL Excluding E&I

Healthcare – Strong Organic Growth

Electronics – +6.8% Growth Excluding E&I

SalesFY 2019

SalesFY 2019

€1,964m

€3,693m

G&S comparable sales growth

strong HHC across Europe, expansion in diabetes

solid Medical Gases in Americas

double digit growth in Carrier Gases and Advanced Materials

significant decrease in E&I compared to 2018 exceptional level

49

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Industrial Merchant Pricing

50

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

FY 2019 E&C and GM&T Activities

(1) Comparable growth (2) Including internal Sales

Engineering & Construction

Sales to third parties(1)

-25%

Order Intake

+4%

Global Markets & Technologies

+15%

+14%

Sales(1)

Order Intake

€838m €523m

€328m €552m

Total Sales(2)

growing

51

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

See definitions in appendix

Dec 2016 Dec 2017 Dec 2018 Decisions Start-ups Dec 2019

Start-upsDecisions

Yearly Sales Backlogafter full Ramp-ups

€2.1bn €2.1bn€2.2bn

€2.8bn

€ 0.9bn

in €bn

Investment Backlog Increased to €2.8bn

52

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

G&S Quarterly Growth Analysis

(1) Comparable growth based on 2016 adjusted sales

(Mainly Tech Air)Base business

+0.2%

53

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Consolidated P&L

54

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Operating Margin (OIR/Revenue)

including +10bps from IFRS 16

Group 15.9% 16.9% 16.4%

Gas & Services 17.8% 18.7% 18.3%

Group 16.6% 18.1% 17.3%

Group - Excl. Energy 16.6% 17.6% 17.1%

Gas & Services 18.4% 19.9% 19.1%

Gas & Services - Excl. Energy 18.4% 19.3% 18.9%

2019H1 2019 H2 2019

H1 2018 H2 2018 2018

55

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Consolidated Balance Sheet Simplified - In €m

* Including fair value of derivatives

56

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Cash Flow Statement

* PPE: Property, plant and equipment.

57

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

Investment Cycle – Definitions

● Investment opportunities at end of the period

– Investment opportunities under consideration by the Group for decision within 12 months.

– Industrial projects with investment value > €5m for Large Industries and > €3m for other business lines.

– Includes asset replacements or efficiency projects. Excludes maintenance and safety.

● Investment backlog at end of the period

– Cumulated industrial investment value of projects decided but not yet started.

– Industrial projects with value > €10m, including asset replacements or efficiency projects, excluding maintenance and safety.

●Sales backlog

– Cumulated expected sales per year generated by the current investment backlog after full ramp-up.

●Decisions of the period

– Cumulated value of industrial and financial investment decisions.

– Industrial, growth and non-growth projects including asset replacements, efficiency, maintenance and safety.

– Financial decisions (acquisitions).

58

The world leader in gases, technologies and services for Industry and HealthCredit InvestorsFull Year 2019

For further information, please contact:

Investor Relations

Aude Rodriguez + 33 (0)1 40 62 57 08

Ludmilla Binet + 33 (0)1 40 62 57 37

Muriel Légeron + 33 (0)1 40 62 50 18

Pierre-Germain Marlier + 33 (0)1 40 62 57 95

Joseph Marczely + 1 610 263 8277

www.airliquide.com Follow us on Twitter @AirLiquideGroup

L’Air Liquide S.A.

Corporation for the study and application of processes developed by Georges Claude

with registered capital of 2,602,080,327 euros

Corporate Headquarters:

75, Quai d’Orsay

75321 Paris Cedex 07

Tel : +33 (0)1 40 62 55 55

RCS Paris 552 096 281

59

Group Financing and Rating

Guillaume Serey + 33 (0)1 40 62 51 78

Aude Revel + 33 (0)1 40 62 56 64

Thomas Lemée + 33 (0)1 40 62 58 25